PIEZO1 and cancer: In addition, long-term survivors also have antibodies against proteins known to promote cancer growth, such as PIEZO1 [24], aggressiveness such as TMPRSS2 [25], and Epithelial Mesenchymal Transition such as KIAA1217 [26] or C11orf45 [27], which are biomarkers related to immune checkpoint proteins.